Inicio › Glioblastoma › Illinois › Chicago
Ensayos clínicos de Glioblastoma en Chicago, IL
15 estudios para Glioblastoma buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
ReclutandoFase 3
- Northwestern University, Chicago
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
ReclutandoFase 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
ReclutandoFase 1
- Northwestern Univerity, Chicago
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
ReclutandoFase 1/2
- Northwestern Memorial Hospital, Chicago
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
ReclutandoFase 1
- Northwestern University, Chicago
Targeted Pediatric High-Grade Glioma Therapy
ReclutandoEstudio observacional
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
ReclutandoFase 1
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Olutasidenib and Temozolomide in HGG
ReclutandoFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- University of Chicago, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
ReclutandoFase 1
- Northwestern Medicine, Chicago
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
ReclutandoFase 2
- Northwestern University, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ReclutandoFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- Northwestern Memorial Hospital, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Chicago
Ensayos de Glioblastoma en otras ciudades
- New York City, NY30 estudios
- Boston, MA28 estudios
- Houston, TX26 estudios
- Los Angeles, CA24 estudios
- Durham, NC20 estudios
- San Francisco, CA17 estudios
- Washington, DC15 estudios
- Miami, FL14 estudios
- Columbus, OH14 estudios
- Rochester, MN13 estudios
- Jacksonville, FL13 estudios
- Aurora, CO12 estudios
Otros estudios en Chicago
- Cáncer de pulmón de células no pequeñas61 estudios
- Cáncer de seno59 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer metastásico45 estudios
- Cáncer de próstata45 estudios
- Cáncer de pulmón41 estudios
- Obesidad41 estudios
- Cáncer de ovario36 estudios
- Cáncer del colon y del recto34 estudios
- Accidente cerebrovascular34 estudios
- Fallo cardíaco31 estudios
- Sobrepeso29 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.